GEA Achieves 10 Percent Operating EBITDA Margin in Q1

26.05.2016

GEA s order intake rose to EUR 1,144.3 million in the first quarter of 2016. Whereas revenue fell, mainly as a result of a low order intake of small, fast-processed orders in the first two months of the year, the order backlog increased by 8.5 percent compared with December 31, 2015.

With the gross margin remaining stable, further cost reductions facilitated by the "Fit for 2020" initiative in particular enabled GEA to improve its operating EBITDA margin by around 20 basis points to 10.0 percent, this despite the contraction in volume.

"Thanks to the measures to enhance efficiency already implemented and our strong position in the market, we succeeded in raising our operating EBITDA margin to 10.0 percent for the first time in a first quarter of a year despite relatively low revenue figures," said Jürg Oleas, Chairman of the Executive Board of GEA, appraising the present situation. "On the basis of solid order intake and a healthy order backlog, we can now corroborate the forecast we made back in February for fiscal year 2016."

Net liquidity continued to improve compared with the prior-year period, increasing from EUR 822.7 million to EUR 867.9. Adjusted for non-recurring items, the cash flow driver margin for the last 12 months amounted to 10.9 percent, compared with 10.2 percent for the prior-year period.

More articles on this topic

ACHEMA 2024: Call for Papers for the ACHEMA Congress Opens

ACHEMA 2024: Call for Papers for the ACHEMA Congress Opens

22.05.2023 -

It’s just over a year away: ACHEMA 2024, the World Forum for Chemical Engineering, Process Engineering and Biotechnology and the world’s leading show for the process industries, will take place in Frankfurt am Main, Germany, from 10 to 14 June 2024. Now the Call for Papers for the ACHEMA Congress opens. Submissions are possible until 6 October 2023.

Read more
Peroxidic-Crosslinked Fluoroelastomer from Freudenberg Meets the Latest Regulatory Requirements of the Process Industry

Peroxidic-Crosslinked Fluoroelastomer from Freudenberg Meets the Latest Regulatory Requirements of the Process Industry

26.04.2023 -

Freudenberg Sealing Technologies’ peroxidic-crosslinked fluoroelastomer material 75 FKM 239961 now also has received pharma-specific approval according to USP Chapter 87. The result of the in vitro conformity test confirms that the material has no toxic effects on cell cultures. With this advancement, bisphenol crosslinked FKM materials can be replaced in the food industry.

Read more
Final Report ACHEMA 2022

Final Report ACHEMA 2022

08.09.2022 -

At ACHEMA 2022, the world’s leading trade show for the process industry, over 2,200 exhibitors from more than 50 countries showcased the latest equipment and innovative processes for the chemical, pharmaceutical and food industries at the Frankfurt fairgrounds from 22 to 26 August.

Read more